IGF1R and osteoporosis: Additionally, this study indicates that p38 MAPK and its related genes (STE20, IGF1R, and TRAF6) are involved in the mechanism of rBMSCs' osteogenic differentiation, which provides experimental evidence of the potential application of PTE in the treatment of osteoporosis.